[1] |
赵辨.中国临床皮肤病学[M]. 南京: 江苏科学技术出版社, 2012:1008⁃1025.
|
[2] |
Davidovici BB, Sattar N, Prinz J, et al. Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co⁃morbid conditions[J]. J Invest Dermatol, 2010,130(7):1785⁃1796. doi: 10.1038/jid.2010.103.
|
[3] |
Gisondi P, Ferrazzi A, Girolomoni G. Metabolic comorbidities and psoriasis[J]. Acta Dermatovenerol Croat, 2010,18(4):297⁃304.
|
[4] |
Gelfand JM, Yeung H. Metabolic syndrome in patients with psoriatic disease[J]. J Rheumatol Suppl, 2012,89:24⁃28. doi: 10.3899/jrheum.120237.
|
[5] |
韩建文, 王勇, 李东霞, 等. 内质网氨基肽酶1基因 rs27044、rs30187和 rs26653多态性与汉族寻常性银屑病相关性研究[J]. 中华皮肤科杂志, 2016,49(4):238⁃242. doi: 10.3760/cma.j.issn.0412⁃4030.2016.04.003.
|
[6] |
Lu Y, Chen H, Nikamo P, et al. Association of cardiovascular and metabolic disease genes with psoriasis[J]. J Invest Dermatol, 2013,133(3):836⁃839. doi: 10.1038/jid.2012.366.
|
[7] |
Cheng H, Li Y, Zuo XB, et al. Identification of a missense variant in LNPEP that confers psoriasis risk[J]. J Invest Dermatol, 2014,134(2):359⁃365. doi: 10.1038/jid.2013.317.
|
[8] |
Prinz JC. Human leukocyte antigen⁃class I alleles and the autoreactive T cell response in psoriasis pathogenesis[J]. Front Immunol, 2018,9:954. doi: 10.3389/fimmu.2018.00954.
|
[9] |
Liu T, Han Y, Lu L. Angiotensin⁃converting enzyme gene polymorphisms and the risk of psoriasis: a meta⁃analysis[J]. Clin Exp Dermatol, 2013,38(4):352⁃358. doi: 10.1111/ced.12106.
|
[10] |
Mohammadi Y, Vaisi⁃Raygani A, Shakiba E, et al. Angiotensin II type 1 receptor A1166 C (rs5186) gene polymorphism increased risk and severity of psoriasis, contribution to oxidative stress, antioxidant statues, lipid peroxidation and correlation with vascular adhesion protein 1, preliminary report[J]. J Eur Acad Dermatol Venereol, 2016,30(8):1395⁃1397. doi: 10.1111/jdv.13241.
|
[11] |
Tang H, Jin X, Li Y, et al. A large⁃scale screen for coding variants predisposing to psoriasis[J]. Nat Genet, 2014,46(1):45⁃50. doi: 10.1038/ng.2827.
|
[12] |
Ellinghaus D, Ellinghaus E, Nair RP, et al. Combined analysis of genome⁃wide association studies for Crohn disease and psoriasis identifies seven shared susceptibility loci[J]. Am J Hum Genet, 2012,90(4):636⁃647. doi: 10.1016/j.ajhg.2012.02. 020.
|
[13] |
Hoffmann TJ, Theusch E, Haldar T, et al. A large electronic⁃health⁃record⁃based genome⁃wide study of serum lipids[J]. Nat Genet, 2018,50(3):401⁃413. doi: 10.1038/s41588⁃018⁃0064⁃5.
|
[14] |
Raza ST, Abbas S, Siddiqi Z, et al. Association between ACE (rs4646994), FABP2 (rs1799883), MTHFR (rs1801133), FTO (rs9939609) genes polymorphism and type 2 diabetes with dyslipidemia[J]. Int J Mol Cell Med, 2017,6(2):121⁃130. doi: 10.22088/acadpub.BUMS.6.2.6.
|
[15] |
李利仲, 孙立, 韩建文, 等. 内蒙古蒙古族寻常性银屑病与HLA⁃Cw*0602,⁃DQB1等位基因的相关性[J]. 中国皮肤性病学杂志, 2012,26(4):283⁃286.
|
[16] |
Purcell S, Neale B, Todd⁃Brown K, et al. PLINK: a tool set for whole⁃genome association and population⁃based linkage analyses[J]. Am J Hum Genet, 2007,81(3):559⁃575. doi: 10.1086/519 795.
|
[17] |
Takai T, Nishita Y, Iguchi⁃Ariga SM, et al. Molecular cloning of MSSP⁃2, a c⁃myc gene single⁃strand binding protein: characterization of binding specificity and DNA replication activity[J]. Nucleic Acids Res, 1994,22(25):5576⁃5581. doi: 10. 1093/nar/22.25.5576.
|
[18] |
Campbell DD, Parra MV, Duque C, et al. Amerind ancestry, socioeconomic status and the genetics of type 2 diabetes in a Colombian population[J]. PLoS One, 2012,7(4):e33570. doi: 10.1371/journal.pone.0033570.
|
[19] |
Qi L, Cornelis MC, Kraft P, et al. Genetic variants at 2q24 are associated with susceptibility to type 2 diabetes[J]. Hum Mol Genet, 2010,19(13):2706⁃2715. doi: 10.1093/hmg/ddq156.
|
[20] |
Kazakova EV, Chen M, Jamaspishvili E, et al. Association between RBMS1 gene rs7593730 and BCAR1 gene rs7202877 and type 2 diabetes mellitus in the Chinese Han population[J]. Acta Biochim Pol, 2018,65(3):377⁃382. doi: 10.18388/abp.2017_ 1451.
|
[21] |
Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance[J]. J Clin Invest, 2006,116(7):1793⁃1801. doi:10. 1172/JCI29069.
|
[22] |
Wang Q, Chang W, Yang X, et al. Levels of miR⁃31 and its target genes in dermal mesenchymal cells of patients with psoriasis[J]. Int J Dermatol, 2019,58(2):198⁃204. doi: 10.1111/ijd.14197.
|
[23] |
Liu R, Wang Y, Zhao X, et al. Lymphocyte inhibition is compromised in mesenchymal stem cells from psoriatic skin[J]. Eur J Dermatol, 2014,24(5):560⁃567. doi: 10.1684/ejd.2014.2394.
|
[24] |
Steinthorsdottir V, Thorleifsson G, Reynisdottir I, et al. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes[J]. Nat Genet, 2007,39(6):770⁃775. doi: 10.1038/ng2043.
|
[25] |
Kang J, Guan RC, Zhao Y, et al. Obesity⁃related loci in TMEM18, CDKAL1 and FAIM2 are associated with obesity and type 2 diabetes in Chinese Han patients[J]. BMC Med Genet, 2020,21(1):65. doi: 10.1186/s12881⁃020⁃00999⁃y.
|
[26] |
Park S, Liu M, Kang S. Alcohol intake interacts with CDKAL1, HHEX, and OAS3 genetic variants, associated with the risk of type 2 diabetes by lowering insulin secretion in Korean adults[J]. Alcohol Clin Exp Res, 2018,42(12):2326⁃2336. doi: 10.1111/ acer.13888.
|
[27] |
Quaranta M, Burden AD, Griffiths CE, et al. Differential contribution of CDKAL1 variants to psoriasis, Crohn′s disease and type II diabetes[J]. Genes Immun, 2009,10(7):654⁃658. doi: 10.1038/gene.2009.51.
|